Australia: SAS-B approvals bounce back after April dip

Australia: SAS-B approvals bounce back after April dip
CANNANNEW REPORT

Cannabiz Australia.. Medicinal cannabis approvals under the Special Access Scheme bounced back in May, with a 26% increase bringing the total to 11,669 for the month, according to latest figures from the TGA. SAS-B approvals since the turn of the year have now topped 50,000, an increase of 24% on the first five months of 2021. Oil accounted for 53% of approvals, slightly up from last month, with flower down from 40% in April to 38% in May. There was a slight increase in approvals for schedule 4 medicine (up from 17% to 20%), but schedule 8 still made up the significant majority at 80%. Chronic pain and anxiety were again the most common indications medicinal cannabis was approved for, accounting for 46% and 32% respectively, followed by sleep disorder (6%), PTSD (3%) and cancer pain (2%). The number of medical practitioners prescribing cannabis in May was 914, up from 814 in April. More at  https://www.cannabiz.com.au/sas-b-approvals-bounce-back-after-april-dip/?utm_medium=email&utm_campaign=Cannabiz%20newsletter%209622&utm_content=Cannabiz%20newsletter%209622+CID_fe79b0c25405ff61b90fb969ef463e3c&utm_source=CampaignMonitor&utm_term=READ%20MORE

Excerpt only …
READ MORE BELOW
Source : Australia: SAS-B approvals bounce back after April dip

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.